Objectives. To determine the availability of nonprescription needles and syringes (NS) through pharmacy sales and to assess the impact of pharmacy policies and municipal paraphernalia laws on pharmacists' selling practices.
INTRODUCTION
Sharing needles and syringes (NS) or injection paraphernalia (e.g., cookers, cotton, rinse water) among injection drug users (IDUs) increases the likelihood of contracting or transmitting human immunodeficiency virus (HIV) and, potentially, other blood-borne pathogens, l'a Providing IDUs with access to sterile injection equipment maybe a major avenue to reduce the risk of such pathogens. 3 However, in many states, paraphernalia and needle possession laws have been instituted to restrict access to injection paraphernalia to those deemed to be in medical need for such equipment. 4 Consequently, IDUs may have difficulty acquiring sterile NS in states with such possession laws.
Some states either have not instituted or have modified or repealed NS possession laws to allow IDUs access to sterile equipment. In these states, pharmacies are a viable option for obtaining sterile NS. However, in states and communities where it is legal to sell NS to anyone, studies have revealed considerable variability in pharmacists' selling behaviors. For example, Gleghorn et al) conducted a telephone survey of Baltimore, Maryland, pharmacists and found that 57% of them reported that they still required a prescription, diabetic identification (DID), or both from anyone who attempted to purchase NS. In a previous study surveying IDUs in Baltimore, half of the IDUs sampled reported NS purchases from pharmacies, and nearly one-third of the sample reported pharmacies as a usual source of NS procurement. 6 In a 1995 national mail survey of the pharmacies in England and Wales, 35% reported selling nonprescription NS; an increase from the 28% of pharmacists found in a 1988 survey with similar samples. 7' 8 Results from Maine revealed that only 15% of surveyed pharmacists reported selling NS to an individual without a prescription or other supporting identification. 9 On the other hand, two surveys in Connecticut, a state where it is legal to purchase a limited number of nonprescription NS, found most pharmacists (83% 10 and 85% ~1) reported selling nonprescription NS.
Alaska has no state laws concerning paraphernalia or needle possession. The Municipality of Anchorage (Alaska's largest city) has a municipal paraphernalia ordinance that discourages merchants selling NS to individuals who are suspected of using NS to inject illicit substances. In the absence of laws that dictate absolute restriction, this municipal ordinance provides considerable discretion to the merchant.
To evaluate the effects of this discretionary power, Lurie and Wolfe ~2 used three research confederates to attempt to purchase NS at several Anchorage pharmacies. These researchers reported that, of 21 pharmacies investigated, only 7 Anchorage pharmacies (33%) were willing to sell NS without a prescription. The purpose of the study was to evaluate the selling practices and attitudes of pharmacists and to assess the degree to which factors such as store policy or paraphernalia laws might affect these practices and attitudes. of theft or robbery, concern for health and HIV prevention, and HIV status of customer; all factors were rated on a 5-point Likert scale that ranged from not at all important (1) to ultimately important (5) . The final part of the interview was concerned with questions regarding the type (i.e., independent, franchise, chain, hospital, or health maintenance organization) and setting of the pharmacy. Completion of the interview took approximately 15 minutes.
The first author who contacted the pharmacies during January 1999 to speak with the pharmacist on duty conducted all interviews. After briefly describing the survey, the interviewer asked whether the pharmacist was willing to participate. To minimize disruption of the pharmacist's regular activities, the telephone interview was arranged around the pharmacists' schedules. For example, the interviewer offered to call back busy pharmacies at times that were more convenient, and when needed to minimize pharmacy business disruption, the interview was paused while the pharmacist helped customers. Individual question response rates varied slightly due to pharmacists' refusals to answer particular questions.
The SAS statistical software package (SAS System 6, SAS Institute, Inc., Cary, NC, 1990) was used to conduct all analyses. Statistics included chi-square test analyses, Wilcoxon rank sum tests, multivariate analysis of variance (MANOVA) using Wilks lambda test criterion, and logistic regression.
RESULTS
Of the 43 pharmacies contacted, 37 (86%) agreed to participate. Fifteen pharmacies were independent, and 22 were part of a chain. Five pharmacies (14%) had store policies permitting NS sales to anyone, 27 (73%) had policies that granted pharmacists discretion in sales, and 5 (13.5%) required prescriptions for all NS sales. In all, 77% (27/35) of pharmacists reported selling nonprescription NS in the last 30 days, with store policies being related significantly to these sales, 
DISCUSSION
The majority (87%) of surveyed Alaskan pharmacies had either no store policy regarding sales of nonprescription NS or had a store policy that granted discretion for such sales to the pharmacist. Of all the pharmacists, 78% reported selling nonprescription NS, a percentage comparable to the 83% and 85% found in the Connecticut studies. 1~' 1~ Despite the presence of an Anchorage paraphernalia ordinance, there were no differences between this and other Alaskan cities in the proportions of pharmacists who reported nonprescription NS sales. This suggests that, when granted discretion for nonprescription NS sales, even with a paraphernalia ordinance, the majority of pharmacists will sell NS without a prescription or DID.
The primary factor associated with the lack of nonprescription NS sales was the presence of a restrictive store policy. However, given that only 14% of the pharmacies had such a policy, it is evident that pharmacies are a viable option for Alaskan IDUs to obtain sterile NS. Previous research demonstrated that most Anchorage IDUs (85%) reported attempting to purchase NS at five specific pharmacies. ~3 One conclusion that might be drawn is that local IDUs learn which pharmacies are more likely to sell nonprescription NS and frequent these businesses for their purchases. In addition, results of the logistic regression analysis revealed a constellation of variables that were not related to nonprescription NS sales, including the pharmacists' reports of customer ethnicity and socioeconomic status.
When examining pharmacist attitudes, those pharmacists who reported selling nonprescription NS were more supportive of NEPs. Although not evaluated, one possible explanation may be that such pharmacists have greater knowledge of the potential of freely accessible NS for the reduction of blood-borne pathogens.
If additional research were to confirm this explanation, one course of action might be more focused education for pharmacists on the role of sterile NS in disease prevention.
Customer sobriety and familiarity with the customer were identified by pharmacists as the most important factors that influence their decision to sell nonprescription NS. Individuals attempting to purchase nonprescription NS via pharmacies should recognize these factors might influence a pharmacist's decision to sell NS, particularly if the pharmacy policy grants discretion to pharmacists regarding nonprescription NS sales.
